Document Detail

Acute hemodynamic effects of the active metabolite of imidapril, (4S)-3-((2S)-2-[N-((1S)-1-carboxy-3-phenyl-propyl)amino]propionyl)-1- methyl-2-oxoimidazolidine-4-carboxylic acid, and enalaprilat in anesthetized dogs.
MedLine Citation:
PMID:  1332727     Owner:  NLM     Status:  MEDLINE    
The hemodynamic effects of imidapril, a novel nonsulfhydryl angiotensin-converting enzyme inhibitor, were examined in anesthetized dogs by the intravenous injection of its active metabolite 6366A ((4S)-3-((2S)-2-[N-((1S)-1-carboxy-3- phenylpropyl)amino]propionyl)-1-methyl-2-oxoimidazolidine-4-carboxylic acid, CAS 89371-44-8) and were compared to those of enalaprilat. 6366A (1-100 micrograms/kg) reduced the blood pressure and total peripheral resistance in a dose-dependent manner, while causing no marked changes in heart rate, LV dp/dtmax, and pulmonary arterial pressure. The cardiac output and stroke volume were slightly increased. Blood flow in the common carotid artery, the vertebral artery, and the femoral artery was reduced or tended to decrease, while the superior mesenteric arterial blood flow was increased. These effects were similar to those of enalaprilat. 6366A did not inhibit the pressor response of angiotensin II, but markedly inhibited that of angiotensin I, and the effects of 6366A on regional blood flow were opposite to those of angiotensin II. Thus, 6366A appears to produce its hemodynamic effects by angiotensin converting enzyme inhibition, as does enalaprilat. 6366A also tended to decrease myocardial oxygen consumption. These results suggested that the hemodynamic effects of imidapril on the heart and on regional blood flow are similar to those of enalapril.
T Ikeo; H Yabana; H Kurosawa; M Kaburaki; K Kikkawa; H Narita; S Murata; I Yamaguchi
Related Documents :
2265047 - Effects of halothane, enflurane and isoflurane anaesthesia on renal plasma flow.
15797677 - Cardiac carnitine leakage is promoted by cardiomyopathy.
16809997 - Noninvasive, automated and continuous cardiac output monitoring by pulmonary capnodynam...
3209977 - In vivo analysis of partitioning of cardiac output between systemic and central venous ...
2995267 - The detection of abscesses with diffusible tracers.
2952497 - Skin blood flow during incremental exercise in a thermoneutral and a hot dry environment.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Arzneimittel-Forschung     Volume:  42     ISSN:  0004-4172     ISO Abbreviation:  Arzneimittelforschung     Publication Date:  1992 Sep 
Date Detail:
Created Date:  1992-12-17     Completed Date:  1992-12-17     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0372660     Medline TA:  Arzneimittelforschung     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  1109-14     Citation Subset:  IM    
Pharmacological Research Laboratory, Tanabe Seiyaku Co., Ltd., Saitama, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
Enalaprilat / pharmacology*
Heart / drug effects
Hemodynamics / drug effects*
Imidazoles / pharmacology*
Myocardium / metabolism
Oxygen Consumption / drug effects
Regional Blood Flow / drug effects
Vascular Resistance / drug effects
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Imidazoles; 0/Imidazolidines; 120294-09-9/imidaprilat; 84680-54-6/Enalaprilat; 89396-94-1/imidapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Suppression of experimental autoimmune encephalomyelitis by a new specific inhibitor of leukotriene ...
Next Document:  1,2,3-triazolo[4,5-h]quinolines. III. Preparation and antimicrobial evaluation of 4-ethyl-4,7-dihydr...